Advisors Asset Management, Inc.
- SEC CIK
- 0001297376
- Latest filing
- Aug 13, 2026
CLVS holding history
Clovis Oncology, Inc. in every 13F filed by Advisors Asset Management, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CLVS overviewAll 13F holders of CLVSFull Q2 2026 holdings
- Shares (Q2 2019)
- 0
- Sold out in Q2 2019
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2018
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2019 | 0 | $0 | 0.0% | −3,315−100.0% | Sold out | – |
| Q1 2019 | 3,315 | $82.3K | <0.1% | −1,128−25.4% | Reduced | – |
| Q4 2018 | 4,443 | $80.0K | <0.1% | −139−3.0% | Reduced | – |
| Q3 2018 | 4,582 | $135.0K | <0.1% | −215−4.5% | Reduced | – |
| Q2 2018 | 4,797 | $218.0K | <0.1% | −274−5.4% | Reduced | – |
| Q1 2018 | 5,071 | $294.0K | <0.1% | – | – | – |
Livermore's 13F data starts with Q1 2018, so Q1 2018 has no change from the previous quarter.